Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

As bioethicists and other experts in human subjects research protection take a closer look at the IRB's role, two interesting questions emerge: First, how can IRBs improve their risk-benefit analyses of trials, and, secondly, should IRBs even be in the business of making risk-benefit determinations?

Should IRB role include risk-benefit analysis?